Search Results 1221-1230 of 18024 for Lupus

1. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

   ... lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease, Crohn's, ulcerative colitis, hepatitis; and patients with a ...

2. Cancer pain: Relief is possible - Mayo Clinic News Network

   The medications and treatment for pain are generally covered by standard insurance. Starting from the beginning may lead to better outcomes for lupus · Mayo ...

3. A Study to Test the Addition of berzosertib to Usual Radiation Treatment for Chemotherapy-Resistant Breast Cancer - Mayo Clinic

   Active systemic lupus, scleroderma, or dermatomyositis with a CPK level above normal. Pregnant women are excluded from this study because berzosertib as a ...

4. Pediatric Optic Neuritis Prospective Outcomes Study - Mayo Clinic

   ... lupus erythematosus, collagen vascular disease, or Lyme disease with overt symptoms beyond serum markers such 356 as rash, peripheral neuropathy, or liver ...

5. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

   Active or history of autoimmune disease or immune deficiency, including, but not limited to, myasthenia gravis, myositis, autoimmune hepatitis, systemic lupus ...

6. Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) - Mayo Clinic

   ... lupus erythematosus, and giant cell arteritis. History of multiple sclerosis. Pregnant or lactating. History of active malignancy within the last 5 years ...

7. Gout - Doctors and departments - Mayo Clinic

   D. Internist; Rheumatologist. Rochester, MN. Areas of focus: Lupus, Scleroderma, Sjogren's syndrome, Gout, Inflammatory myopathy, Inflammatory arthritis. There ...

8. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

   Known intestinal autoimmune disease including celiac disease, ulcerative colitis, Crohn's disease, lupus erythematosus, scleroderma, or other autoimmune ...

9. A Study to Evaluate the Effect of POSE2 on Long-term Gastric Motor Function - Mayo Clinic

   History of a known diagnosis or pre-existing symptom of rheumatoid arthritis, scleroderma, system lupus, or other autoimmune connective tissue disorder.

10. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

    History or risk of autoimmune disease, including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease ...